CML

Clinical trials for CML explained in plain language.

Never miss a new study

Get alerted when new CML trials appear

Sign up with your email to follow new studies for CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 2 Terminated 1

New drug combo tested for Tough-to-Treat blood cancers

Disease control Terminated

This early-phase study tested whether adding the drug rapamycin to a standard high-dose chemotherapy regimen (HiVAC) was safe and effective for adults with aggressive blood cancers that had returned or stopped responding to previous treatments. The goal was to see if this combina…

Matched conditions: CML

Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

CML

Get alerted when new CML trials appear

New drug combo tested for Tough-to-Treat blood cancers